drugset / Trial / NCT01308541
A Study to Characterize Pharmacokinetics (PK) and Pharmacodynamics (PD) of LUSEDRA® Administered as Continuous Infusion or Bolus Compared With Continuous Infusion of Propofol Injectable Emulsion
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to explore the pharmacokinetics (PK) and pharmacodynamics (PD) of LUSEDRA® administered as a continuous infusion or bolus compared with continuous infusion of propofol injectable emulsion.
Timeline
- Start
- 2011-01
- Primary completion
- 2011-08
- Completion
- 2011-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Propofol | Small molecule | 14 mg/kg | Intravenous |
| Comparator | fospropofol | Small molecule | 42 mg/kg | Intravenous |
Indications
No indication recorded.